- Cambridge University, LL.M., 2001
- Boston University School of Law, J.D., 1998
- Magna cum laude
- Journal of Science and Technology Law, Managing Editor
- Clarkson University, B.S., 1995
- District of Columbia
Kerry Shannon Burke is a partner in the corporate and securities practice areas. The focus of Ms. Burke’s practice is on capital markets and securities transactions. She has a broad range of experience representing companies, ranging from development stage ventures to large public issuers, as well as underwriters and other institutional investors, in private and public debt and equity financings. Ms. Burke also has assisted clients on a range of finance and merger and acquisition transactions.
Ms. Burke regularly advises on general corporate and federal securities law matters, including assisting public companies in the preparation of periodic reports under the Securities Exchange Act of 1934 and on other securities law compliance matters, including under the JOBS Act and the Dodd-Frank Act.
Ms. Burke also is an expert on the Investment Advisers Act of 1940 and advises registered and unregistered investment advisers, including private equity funds, hedge funds and venture capital funds, on various status questions and ongoing compliance matters.
- Advised on private and public securities offerings for Pepco Holdings, Inc. and its subsidiaries with an aggregate value of over $6.9 billion, including the issuance of first mortgage bonds, senior notes, “fading lien” bonds and tax-exempt bonds.
- Represented Pepco Holdings, Inc. and its subsidiaries in their significant finance matters, including syndicated and bilateral credit facilities, commercial paper programs, bridge acquisition facilities, a credit intermediation arrangement and various swap transactions.
- Represented Avnet, Inc. in a registered offering of $350.0 million of 4.875% Notes due 2022.
- Represented Eli Lilly and Company in a $1.0 billion registered offering of notes, consisting of $600.0 million of 1.950% notes due 2019 and $400.0 million of 4.650% notes due 2044.
- Represented Salix Pharmaceuticals, Ltd. in its $750.0 million offering of 6.00% senior notes due 2021.
- Represented Omeros Corporation in offerings of common stock in an aggregate amount of $95.7 million, including in connection with an at-the-market facility.
- Represented Omeros Corporation in connection with a senior secured credit facility.
- Represented a public company issuer in cash tender offers for its outstanding debt securities and related consent solicitation.
- Represented the lenders in the refinancing of the senior secured credit facility for the Verizon Center.
- Represented a provider of mobile satellite communications in a $230 million private placement.
- Advised U.S. Digital Television LLC in restructuring its operations and in a subsequent preferred membership unit investment by a group of strategic investors.
- Represented XLHealth Corporation in a $240 million private placement to a private equity investor and in a preferred stock investment by venture capital investors.
- Represented various emerging growth companies in bridge financings and in refinancing secured lines of credit.
- Assisted public companies in the preparation of periodic reports under the Securities Exchange Act of 1934 and on other securities law compliance matters.
- Assisted various private funds with the investment adviser registration process, including drafting Form ADVs and compliance policies and procedures.
- Provided ongoing compliance advice to investment advisers, including with respect to custody, pay-to-play, performance advertising and OCIE examination issues.
Honors and Rankings
- Washington DC Super Lawyers, Securities & Corporate Finance (2014)
- Legal 500 US, Finance - Capital Markets (2013-2014)
- Counseled a large museum and research organization on outstanding debt instruments.
Publications and Speeches